We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Poolbeg Pharma Plc | LSE:POLB | London | Ordinary Share | GB00BKPG7Z60 | ORD 0.02P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -0.17 | -2.31% | 7.18 | 7.10 | 7.30 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 7.35 | 7.20 | 7.35 | 389,436 | 16:35:13 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 0 | -3.93M | -0.0079 | -9.11 | 36.75M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 09/12/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC Poolbeg presents POLB 001 data at 66th ASH Meeting |
| 20/11/2024 | 18:26 | ALNC |  Poolbeg Pharma granted US patent for influenza treatment |
| 20/11/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC POLB 001 Patent Granted in United States |
| 06/11/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC POLB 001 data to be presented at ASH |
| 18/9/2024 | 06:00 | UK RNS | Poolbeg Pharma PLC Interim results for the six months to 30 June 2024 |
| 27/8/2024 | 06:00 | UK RNS | Poolbeg Pharma PLC H.C. Wainwright Global Investment Conference |
| 12/8/2024 | 12:28 | UK RNS | Poolbeg Pharma PLC Holding(s) in Company |
| 26/7/2024 | 17:59 | ALNC | EARNINGS AND TRADING: Man Group profit rises; Petershill AUM increases |
| 26/7/2024 | 06:00 | UK RNS | Poolbeg Pharma PLC Voluntary Delisting from OTCQB Market |
| 10/7/2024 | 06:00 | UK RNS | Poolbeg Pharma PLC Notification of Major Holdings |
1 Year Poolbeg Pharma Chart |
Intraday Poolbeg Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
